450 likes | 605 Views
The Patient Protection and Affordable Care Act. Update and Implications 2013 Annual Conference: AIDS Drug Assistance Programs: Renewing the Commitmen t. Joseph Jefferson, MPH Director of Advocacy and Alliance Development. Presentation Preview. Assessing the Landscape
E N D
The Patient Protection and Affordable Care Act Update and Implications 2013 Annual Conference:AIDS Drug Assistance Programs: Renewing the Commitment Joseph Jefferson, MPH Director of Advocacy and Alliance Development
Presentation Preview • Assessing the Landscape • ACA Implementation Update • ACA Patient Protections and Access • ACA and Ryan White • ACA and Implications for ADAP • Informing the Advocacy Agenda
Workforce Trends • Approximately 4,500 HIV providers (MD, DO, NP, PA) in US1 • Fewer than 1/3 of physicians are in private practice – migrating to larger health systems • The current HIV workforce is composed of first-generation providers who entered the field over 20 years ago • 50% of current HIV provider workforce retiring in next 5-10 years • Ryan White Part C-funded clinicsreport difficulty recruiting HIV clinicians 1 Physician Workforce Projections in an Era of Health Care Reform, Annual Review of Medicine, Vol. 63: 435-445, February 2012
PCP Role in Treating Co-occurring Conditions • Providers of HIV Care reported increasing numbers of HIV patients with co-occurring conditions like: • Cardiovascular disease (50%) • Renal disease (49%) • Mental health conditions (48%) • Substance abuse (38%) • Hepatitis C (36%) • 58% of HIV Providers are seeing increasing number of HIV patients with sexually transmitted infections
ACA Implementation Update
Implementation Benchmarks January 2013 January 2014 • State Notification Regarding Exchanges • Closing the Medicare Drug Coverage Gap • Medicaid Coverage of Preventive Services • Medicaid Payments for Primary Care • Medicaid Expansion • Individual Insurance Requirement • Health Insurance Exchanges • Guaranteed Availability of Insurance • No Annual Limits on Coverage • Essential Health Benefits
Medicaid Expansion Decision Map Kaiser Family Foundation, July 2013
Marketplace (Exchange) Decision Map Kaiser Family Foundation, July 2013
Key ACA Patient Protections • Guaranteed availability of coverage, regardless of health status or pre-existing condition • Prohibitions on discriminatory premium rates, ie. gender and health status • Coverage of “specified” preventive health services without cost-sharing • Low-income PWLHs <64 may qualify for Medicaid in states that choose to expand
Key ACA Patient Protections • No lifetime or annual limits on coverage • Prohibitions on illness-related coverage discontinuation • Federal subsidies for people with incomes <400% FPL • Plans have to contract with “community providers”, including Ryan White programs • Plans must include EHB
PLWHs and Access http://policyinsights.kff.org/2012/september/how-the-aca-changes-pathways-to-insurance-coverage-for-people-with-hiv.aspx
ACA & the HCV Paradox • Increased Demand for Linkage and Retention • Increased HCV Screening • Increased Access to Coverage • Increased Demand on Service Delivery System • Increased Detection and Diagnosis • Stronger Case for National Surveillance System • Increased Emphasis on Prevention • Increased Treatment and Monitoring • Increased Urgency to Codify Prescription Drug Coverage Standards
Ryan White Reauthorization Update • Ryan White will likely not be reauthorized in 2013 – though 2009 reauthorization contains no sunset provision • Programs will likely continue in FY 14 and beyond • Final FY13 CR did not include Obama’s proposed emergency funding: $35M for ADAPs and $10M for PartC • Sequester likely to result in 5.2% HHS funding reduction • Obama FY14 budget provides $20M increase in RW • $10M ADAP; $10 for Part C clinics • As ACA is implemented FQHCs are likely to see an influx of HIV patients
Ryan White Reauthorization Update HRSA Justification Notes: “The Ryan White Program is authorized through September 30, 2013. However, the program will continue to operate. The 2009 reauthorization or the Ryan White HIV/AIDS Treatment Extension Act of 2009 (P.L. 111-87, October 30, 2009) does not include an explicit sunset clause. In the absence of a sunset clause, the program will continue to operate without a Congressional reauthorization.”
Ryan White Reauthorization Update HRSA/HAB Policy Considerations: • Identify issues as RW beneficiaries transfer to private insurance • Reallocate RW dollars toward premium support • Create flexible enrollment procedures & timelines • Clarify effective coverage dates • Recommend n=Network v. out-of-Network care policies • Assess impact of prior authorization for both Medicaid and Marketplaces
Federal RW Funding (infl-adj) and HIV Prevalence, 1991-2012 Source: Andrea Weddle, HIV Medicine Association, HIV Medical Provider Experiences: Results of a Survey of Ryan White Part C Programs, Institute of Medicine Committee on HIV Screening and Access to Care, September
ACA & Implications for ADAP
HealthHIV HealthGram on Medicaid Expansion & HIV Incidence by State and Health Ranking
Estimated % of ADAP Clients Newly Eligible for Medicaid in 2014: Top Quartile Medicaid Eligibility ≠ Medicaid Access Only 2 of 12 top quartile states (Illinois and Michigan) are expanding Medicaid
Estimated % of ADAP Clients Newly Eligible for Medicaid in 2014: Bottom Quartile 7 of 12 bottom quartile states are expanding Medicaid http://www.hivhealthreform.org/wp-content/uploads/2013/03/50-states-Modeling-Final.pdf
Estimated % of ADAP Clients NEWLY Eligible for Private Insurance Subsidies in 2014: Top Quartile Federally Facilitated Exchange: 8 States Partnership Exchange: 2 States State-based Exchange: 2 States http://www.hivhealthreform.org/wp-content/uploads/2013/03/50-states-Modeling-Final.pdf
Estimated % of ADAP Clients Eligible for Private Insurance Subsidies IN 2014: Bottom Quartile Federally Facilitated Exchange: 4 States Partnership Exchange: 3 States State-based Exchange: 5 States http://www.hivhealthreform.org/wp-content/uploads/2013/03/50-states-Modeling-Final.pdf
Informing the Advocacy Agenda
Medicaid 1. HHS/CMS must: • Ensure “Alternative Benefit Plan” is similar to traditional Medicaid • Give states flexibility to design multiple ABPs targeting specific populations • Extend EHB non-discrimination mandates to ABPs • Apply rules governing prescription drug coverage under Medicaid to ABP • Apply non-disc protections to drug benefit • Include preventive services, including routing HIV and HCV screening • Mitigate burdensome cost-sharing proposals by adopting standard established in Medicare Part D low-income subsidy program 2. Advocates must press for Medicaid expansion in states leaning against expansion
Essential Health Benefits 1. CMS must: • Evaluate and standardize “medical necessity” requirements • Develop mechanisms to monitor utilization management techniques, exclusions, and service limits • Ensure meaningful stakeholder engagement involvement at Federal and State level in the run-up to EHB framework reevaluation in 2016 – Goal: Higher and more clearly defined national standards • Issue clarifying guidance to states to ensure reasonable, accessible, and expedited appeals process regarding benefit and service coverage decisions – including access to most appropriate and effective combination ARV therapy 2. Advocates need to work with CMS to overcome opposition by payers
Ryan White • Persuade Obama Administration to restore $35M for ADAP and $10M for Part C (lost in CR) – We’ve almost checked this one. • Preserve RW program funding through budget process (FY14 and beyond) – We feel pretty good about this one. • Engage Members and their staffs in ongoing education about how RW funding helps to reduce community viral load – and new infections • Work with HRSA/HAB to ensure transition issues remain a priority • Integrate HIV care into mainstream health system • Fortify collaborations between RW medical and support service providers • Strengthen focus on gay and bisexual men • Resource distributions that align with post-ACA coverage gaps - especially in states that are not expanding Medicaid • Conduct research to assess and identify scalable and effective interventions that link performance along the cascade
HCV • Press for national data system and/or standards for hepatitis data collection • Increase funding for hepatitis prevention • Institute national screening protocols • Clarify EHB prescription drug coverage standards (given new HCV treatment opportunities in the pipeline) • Address ADAP HCV drug formularies • Develop and resource education initiatives targeted at provider, consumers, and broader public
Federal HCV Initiatives • Healthy People 2020 (Dec 2010) • Goal: Increase immunization rates and reduce preventable infectious diseases • National Viral Hepatitis Action Plan (May 2011) • Increase % of persons aware of HBV infection from 33% to 66% • Increase % of persons aware of HCV infection from 45% to 66% • Reduce number of new cases of HCV by 25% • Elimination of mother-to-child transmission of HBV • CDC recommendations on HCV testing for baby boomers (August 2012) • Patient Protection and Affordable Care Act (2014) • Focus on prevention
Where Can I Obtain Additional Information? • HHS • www.healthcare.gov • CMS – Medicaid • Medicaid.gov • CMS – CCIIO • cciio.cms.gov • HRSA • hab.hrsa.gov/affordablecareact/index.html • For any questions related to RW and the ACA, please email: RWP-ACAQuestions@hrsa.gov
Washington, DC 20009202.232.6749 www.healthhiv.org joseph@healthhiv.org 202.507.4727